Tutorials › Model-Informed Drug Development (MIDD) › Correlated Outcomes in Benefit-Risk Assessment

Quantitative Benefit-Risk Assessment · Tutorial 340 of 596

Correlated Outcomes in Benefit-Risk Assessment

Use joint outcome probabilities to calculate expected utility and assess how dependence between efficacy and toxicity affects a benefit-risk conclusion.

Advanced 11 min read

What You'll Learn

  • Define joint and marginal outcome distributions for efficacy and toxicity.
  • Calculate expected utility from a joint probability table.
  • Explain why dependence matters for interacting, but not additive, utility.
  • Compare an observed joint distribution with an independence assumption.
  • Assess how feasible dependence patterns can change a treatment comparison.

Why the Joint Distribution Matters

A patient may experience both a treatment benefit and a toxicity during the same follow-up period. Summarizing the probability of benefit and the probability of toxicity separately does not tell us how often these outcomes occur together. That overlap matters when the value assigned to a benefit depends on whether toxicity also occurred, or when utility is otherwise non-additive.

The earlier material on averaging utilities establishes the basic calculation: multiply each possible outcome’s utility by its probability and sum. For efficacy and toxicity assessed on the same patients over the same horizon, the relevant probabilities may be joint probabilities. Replacing them with probabilities constructed as if the outcomes were independent can change expected utility—and, in some cases, the preferred treatment.

Definition: Let \(B\) describe an efficacy outcome and \(T\) a toxicity outcome for the same patient over a specified assessment period. Their joint outcome distribution assigns a probability \(P(B=b,T=t)\) to each pair of outcomes. The marginal distribution of \(B\) or \(T\) gives probabilities for that outcome alone, summing over the possible values of the other outcome. The outcomes are independent if \(P(B=b,T=t)=P(B=b)P(T=t)\) for every pair \((b,t)\).

For discrete outcomes, expected utility is calculated over the joint distribution:

$$ E[U(B,T)] = \sum_b \sum_t U(b,t)P(B=b,T=t). $$

This calculation assumes the outcome categories and their utilities are defined on a common, clinically meaningful assessment horizon; the joint probabilities refer to the same target population; and the probabilities form a valid distribution (they are nonnegative and sum to one). The utility function must also represent the stated preferences for each possible outcome pair. If outcomes are continuous, the corresponding calculation integrates utility over their joint density.

Dependence and Utility Interaction

Consider binary indicators: \(B=1\) means the patient experiences the specified efficacy outcome, and \(T=1\) means the patient experiences the specified toxicity. Let \(p_B=P(B=1)\), \(p_T=P(T=1)\), and \(q=P(B=1,T=1)\). The four joint probabilities are \(q\), \(p_B-q\), \(p_T-q\), and \(1-p_B-p_T+q\). Their nonnegativity implies:

$$ \max(0,p_B+p_T-1) \leq q \leq \min(p_B,p_T). $$

Thus, knowing both marginal probabilities generally does not determine how often benefit and toxicity occur together. Independence supplies one particular value, \(q=p_Bp_T\), but it is an assumption, not a consequence of knowing the two marginals.

For binary outcomes, any utility table can be written as \(U(B,T)=a+bB+cT+dBT\), where \(a\), \(b\), \(c\), and \(d\) are determined by its four utility values. Specifically, \(a=U(0,0)\), \(b=U(1,0)-U(0,0)\), \(c=U(0,1)-U(0,0)\), and \(d=U(1,1)-U(1,0)-U(0,1)+U(0,0)\). Taking expectations gives:

$$ E[U(B,T)] = a+bp_B+cp_T+dq. $$

The coefficient \(d\) measures the interaction in the utility table: it is the extra change in utility when both outcomes occur, beyond the changes represented by the separate benefit and toxicity terms. Since \(\operatorname{Cov}(B,T)=q-p_Bp_T\), the difference between expected utility under the actual joint distribution and under independence is:

$$ E[U(B,T)]-E_{\mathrm{ind}}[U(B,T)] =d(q-p_Bp_T)=d\operatorname{Cov}(B,T). $$

For binary outcomes with nonzero variances, \(\operatorname{Cov}(B,T)=\rho\sqrt{p_B(1-p_B)p_T(1-p_T)}\), where \(\rho\) is their correlation. This identity shows why correlation alone is not enough to determine the direction or size of the utility change: both the utility interaction and the dependence matter.

Worked Example: Calculating Utility From a Joint Distribution

Suppose a hypothetical treatment has \(p_B=0.60\) and \(p_T=0.30\). A joint model estimates the probabilities shown below. Utility is measured in preference points: benefit alone is worth 10 points, toxicity alone costs 8 points, and experiencing both has utility \(-4\) points.

Toxicity: \(T=0\)Toxicity: \(T=1\)Total
No efficacy: \(B=0\)0.340.060.40
Efficacy: \(B=1\)0.360.240.60
Total0.700.301.00

The table is coherent: its cells are nonnegative, sum to 1.00, and reproduce both stated marginal probabilities. The expected utility using the joint distribution is:

$$ E[U]=0.34(0)+0.06(-8)+0.36(10)+0.24(-4) =-0.48+3.60-0.96=2.16\text{ preference points}. $$

Under independence, the probability of both outcomes would instead be \(0.60(0.30)=0.18\). The four independent probabilities would be 0.28 for neither outcome, 0.42 for efficacy without toxicity, 0.12 for toxicity without efficacy, and 0.18 for both. The corresponding calculation is:

$$ E_{\mathrm{ind}}[U]=0.28(0)+0.12(-8)+0.42(10)+0.18(-4) =-0.96+4.20-0.72=2.52\text{ preference points}. $$

Independence overstates expected utility by \(2.52-2.16=0.36\) points. Here \(q=0.24\), so the covariance is \(0.24-(0.60)(0.30)=0.06\). The utility interaction is \(d=-6\), and \(d\operatorname{Cov}(B,T)=(-6)(0.06)=-0.36\), matching the direct calculation.

When Dependence Does Not Change Expected Utility

It is important not to conclude that correlation always changes expected utility. If utility is additive in benefit and toxicity, then \(d=0\). In that case, expected utility depends only on the marginal probabilities, even when the outcomes are correlated. This is a mathematical property of additive utility—not evidence that the outcomes are independent.

Worked Example: Additive Utility With Correlated Outcomes

Use the joint probabilities from the previous example, but suppose utility is \(U(B,T)=10B-8T\), with no additional utility effect for experiencing both outcomes. The expected utility from the joint table is:

$$ E[U]=0.34(0)+0.06(-8)+0.36(10)+0.24(2) =-0.48+3.60+0.48=3.60\text{ preference points}. $$

Equivalently, the marginal calculation is \(10(0.60)-8(0.30)=6.00-2.40=3.60\) points. Under independence, the four utilities are 0, \(-8\), 10, and 2, so:

$$ E_{\mathrm{ind}}[U]=0.28(0)+0.12(-8)+0.42(10)+0.18(2) =-0.96+4.20+0.36=3.60\text{ preference points}. $$

The joint probabilities differ, but expected utility does not. A dependence analysis is still useful for understanding which patients experience both outcomes; it is simply not needed to calculate this particular additive expected utility when the marginals are known.

Checking the Direction and Consequences of Dependence

When utility includes an interaction, positive dependence can raise or lower expected utility depending on the sign of \(d\). In the first example, the combined outcome had a lower utility than would be implied by adding the separate benefit and toxicity contributions, so \(d\) was negative. Positive covariance then reduced expected utility relative to independence. With a positive interaction, the same positive covariance would increase expected utility.

Worked Example: Dependence Can Change a Treatment Comparison

Continue with \(p_B=0.60\), \(p_T=0.30\), and \(U(B,T)=10B-8T-6BT\). Suppose the hypothetical joint distribution instead has \(q=0.08\). The other cells must be \(P(B=1,T=0)=0.60-0.08=0.52\), \(P(B=0,T=1)=0.30-0.08=0.22\), and \(P(B=0,T=0)=1-0.52-0.08-0.22=0.18\). These probabilities are nonnegative and sum to 1.00, with the required marginals.

Expected utility is:

$$ E[U]=0.18(0)+0.22(-8)+0.52(10)+0.08(-4) =-1.76+5.20-0.32=3.12\text{ preference points}. $$

Independence would give 2.52 points, as calculated earlier. The difference is \(3.12-2.52=0.60\) points. This also follows from \(d(q-p_Bp_T)=(-6)(0.08-0.18)=0.60\). The outcomes are negatively associated in this distribution: benefit and toxicity co-occur less often than independence predicts.

For illustration, suppose a hypothetical comparator has expected utility of 2.30 points on the same scale. The joint-distribution estimate of 3.12 points favors the treatment, as does the independence estimate of 2.52 points. By contrast, the joint distribution in the first example gave 2.16 points, below the comparator, while independence gave 2.52 points, above it. Thus the independence assumption can reverse the ranking when the expected-utility difference is small enough.

Modeling and Diagnosing the Joint Distribution

A joint distribution may be estimated directly from paired outcomes, or represented through a marginal model and a conditional model. For example, the identity \(P(B,T)=P(B)P(T\mid B)\) is valid by the definition of conditional probability when \(P(B)>0\). Setting \(P(T\mid B)=P(T)\) for all relevant values of \(B\) imposes independence. The chosen representation should match the available data and make the dependence assumption explicit.

Useful checks include confirming that cell probabilities are nonnegative and sum to one, verifying that row and column totals reproduce the intended marginals, and comparing the estimated co-occurrence with the independence prediction. For binary outcomes, compare \(q\) with \(p_Bp_T\); for more outcome categories, inspect the joint table or an appropriate dependence summary. Sparse or empty cells can make joint estimates unstable, especially for uncommon outcomes. A fitted joint model should therefore be checked for implausible probabilities and sensitivity to reasonable alternative dependence assumptions.

If only the marginal probabilities are available, the dependence is not identified from those marginals alone. The feasible range for \(q\) can still be used to assess how much expected utility could vary under different joint distributions. In the examples, \(p_B=0.60\) and \(p_T=0.30\) allow \(0\leq q\leq0.30\). For the interacting utility \(10B-8T-6BT\), expected utility is \(3.60-6q\), so this range permits values from 3.60 points at \(q=0\) to 1.80 points at \(q=0.30\). This is a dependence sensitivity range, not a confidence interval.

1
Define paired outcomes.
Specify the efficacy and toxicity categories for the same patients and the same assessment horizon.
2
Specify utilities.
Assign utility to every possible outcome combination, including combinations in which both efficacy and toxicity occur.
3
Use a joint distribution.
Estimate or justify the probabilities of the outcome combinations; do not infer independence merely from having separate marginal estimates.
4
Check sensitivity.
Compare expected utility under the joint model with independence and, where dependence is uncertain, with feasible alternatives.

A joint model is not automatically preferable in every setting. It can require more data and more modeling assumptions than separate marginal models, while sparse joint cells may be difficult to estimate reliably. Conversely, assuming independence for convenience can conceal clinically important co-occurrence. Association between outcomes also does not establish that one outcome causes the other; this calculation describes their joint distribution and its implications for utility, not a causal mechanism.

Common pitfall: “The efficacy rate and toxicity rate are known, so multiplying them gives the probability of both.” That multiplication is correct only under independence. The correction is to use an estimated or justified joint probability; if that is unavailable, state the independence assumption and assess how alternative feasible joint probabilities affect expected utility.

Check Your Understanding

Answer each question using the definitions and calculations in this tutorial. Short solutions follow.

  1. If \(p_B=0.50\) and \(p_T=0.20\), what joint probability of benefit and toxicity does independence imply?
  2. For binary \(B,T\), a utility table has no interaction term (\(d=0\)). Does dependence affect its expected utility when the marginal probabilities are fixed? Explain.
  3. With \(p_B=0.60\), \(p_T=0.30\), and \(q=0.24\), calculate the covariance and state whether the outcomes show positive or negative association.
  4. For \(U(B,T)=10B-8T-6BT\), calculate expected utility when \(p_B=0.60\), \(p_T=0.30\), and \(q=0.20\).

Solutions. (1) Independence implies \(P(B=1,T=1)=p_Bp_T=(0.50)(0.20)=0.10\). (2) No. With \(d=0\), expected utility is \(a+bp_B+cp_T\), which does not contain \(q\); dependence does not change expected utility for fixed marginals. (3) \(\operatorname{Cov}(B,T)=q-p_Bp_T=0.24-(0.60)(0.30)=0.06\). The positive covariance indicates positive association. (4) \(E[U]=10p_B-8p_T-6q=10(0.60)-8(0.30)-6(0.20)=6.00-2.40-1.20=2.40\) preference points.